期刊文献+

北京市石景山区健康人群甲流抗体水平及疫苗免疫效果

Serum level of antibodies against influenza A (H1N1) at baseline and after vaccination among healthy people in Shijingshan district of Beijing in 2009
下载PDF
导出
摘要 目的了解北京市石景山区健康人群甲型H1N1流感抗体水平及疫苗的免疫效果。方法随机选取10个年龄组共236人作为人群抗体水平监测对象,其中83人作为疫苗免疫效果评估对象,共采集319份静脉血采用血凝抑制试验测定H1抗体。结果健康人群中抗体阳性率为31.36%,几何平均滴度(GMT)为1∶17.22,各年龄组间差异有统计学意义(χ2=57.43,P<0.001;F=9.12,P<0.001),20~59岁组水平最低,职业分布与年龄分布相一致。监测免疫后人群83人,抗体阳性率为95.18%,GMT为1∶184.41,显著高于免疫前水平(χ2=70.58,P<0.001;F=17.59,P<0.001)。结论石景山区人群已具有一定的甲型H1N1流感保护性抗体水平,甲型H1N1流感疫苗具有良好的流行病学保护效果。 Objective To understand serum level of antibody against influenza A (H1N1) virus at baseline and after vaccination among healthy people in Shijingshan district of Beijing to provide scientific basis for further promotion of its vaccination. Methods A total of 236 people at various age groups were selected for the study, 83 for evaluating immunological effects after vaccination. In total, 319 serum specimens were collected to detect hemagglutination-inhibition (HI) antibody against 2009 influenza A (H1N1) virus.Results Prevalence of the protective antibody in healthy people was 31.36 percent with geometric mean titer (GMT) of 1∶17.22 before vaccination. There was significant differences in prevalence and GMT of antibody against influenza A (H1N1) among varied age groups (χ2=70.58, P0.001 and F=17.59, P0.001, respectively), with the lowest prevalence and GMT at groups of 20~59 years old. Distribution of serum prevalence of influenza A (H1N1) antibody by occupation was consistent with that by age. Prevalence of the antibody and GMT were 95.18 percent and 1∶184.41, respectively after vaccination, significantly higher than those before it (χ2=70.58, P0.001 and F=17.59, P0.001, respectively).Conclusion About 31 percent of healthy people in Shijingshan district show serum protective antibody against 2009 influenza A (H1N1) virus before vaccination, and a better immunological effect of influenza A (H1N1) vaccine has been observed after vaccination.
出处 《首都公共卫生》 2011年第3期98-101,共4页 Capital Journal of Public Health
关键词 甲型H1N1流感 血凝抑制试验 几何平均滴度 疫苗效果监测 Influenza A (H1N1) Hemagglutination-inhibition assays Geometric mean titer (GMT) Surveillance immunological effect vaccine
  • 相关文献

参考文献7

二级参考文献13

  • 1卫生部《甲型H1N1流感诊疗方案(2009年试行版第1版)》.2009. http://www, moh. gov. cn/publicfiles/business/htmlfiles/ mohyzs/s3585/200905/40478.htm.
  • 2卫生部《甲型H1N1流感监测方案(第1版)》.2009.http://www.moh. gov. cn/publicfiles/business/htmlfiles/mohjbytkzj/s3578/ 200905/40506. htm.
  • 3卫生部《甲型H1N1流感密切接触者判定和管理方案(试行)》.2009. http://www, moh. gov. cn/publicfiles/business/htmlfiles/ mohjbytkzj/s3578/200905/40506, htm.
  • 4卫生部《甲型H1N1流感疫源地消毒指南(试行)》.2009.http://www. moh. gov. cn/publicfiles/business/htmlfiles/mohjbyfkzj/ s3578/200905/40506, htm.
  • 5Ferguson NM, Cummings DA, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature, 2005,437 ( 7056 ) : 209-214.
  • 6World Health Organization. Influenza-like illness in the United States and Mexico, 2009 [ OL ]. Available from: http://www. who. int/csr/don/ 2009_04_24/en/index. html.
  • 7北京市卫生局.北京市报告一例甲型H1N1流感确诊病例,2009[OL].http://www.bjhb.gov.cn/news.do?dispath=readByld&id=24766.
  • 8CDC. Update : swine influenza A /H1N1 infections2Califomi2aand Texas, April 2009. MMWR Morb Mortal WklyRep, 2009, 58:435-437.
  • 9CDC. Use of influenza A/H1N1 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2009. MMWR Recomm Rep,2009,58.
  • 10庹晓莉,彭中,王成,孙丁,速丽媛,岳勇,张亚兰,尹仲良.中国首例甲型H1N1流感确诊病例流行病学调查[J].中华流行病学杂志,2009,30(10):1087-1088. 被引量:18

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部